MediWound (MDWD) Capital Expenditures (2013 - 2025)
MediWound's (MDWD) quarterly Capital Expenditures came in at $8.6 million in Q4 2025, up 67.05% year-on-year from $5.1 million in Q4 2024, and up 918.95% quarter-over-quarter from -$1.0 million in Q3 2025.
MediWound (MDWD) Capital Expenditures (2013 - 2025) Analysis & Trends
MediWound's Capital Expenditures history runs 13 years deep, the most recent figure standing at $8.6 million for Q4 2025.
- On a quarterly basis, Capital Expenditures rose 67.05% year-over-year to $8.6 million in Q4 2025; TTM through Dec 2025 was $5.5 million, a 1700.29% increase from a year earlier, with the FY2025 full-year figure at $5.5 million, up 1700.29% from the prior year.
- Capital Expenditures improved to $8.6 million in Q4 2025 per MDWD's latest filing, from -$1.0 million in the prior quarter.
- Across five years, Capital Expenditures topped out at $10.7 million in Q4 2023 and bottomed at -$3.0 million in Q2 2024.
- The 5-year median for Capital Expenditures is -$959000.0 (2025), against an average of $645117.6.
- Across the five-year window, Capital Expenditures jumped 74.0% in 2021 and sank 840.62% in 2023, its largest moves.
- Year by year, Capital Expenditures stood at -$116000.0 in 2021, then dropped by 18.97% to -$138000.0 in 2022, then soared by 7867.39% to $10.7 million in 2023, then plunged by 52.21% to $5.1 million in 2024, then jumped by 67.05% to $8.6 million in 2025.
- Per Business Quant, the three latest MDWD Capital Expenditures figures stand at $8.6 million (Q4 2025), -$1.0 million (Q3 2025), and -$1.0 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | MediWound | 183.16 Mn | 178.36 Mn | 278,000.00 | 8.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 8.56 Mn |
| Dec 31, 2025 | 8.56 Mn |
| Sep 30, 2025 | -1.05 Mn |
| Sep 30, 2025 | -1.05 Mn |
| Jun 30, 2025 | -1.05 Mn |
| Jun 30, 2025 | -1.05 Mn |
| Mar 31, 2025 | -959,000.00 |
| Mar 31, 2025 | -959,000.00 |
| Dec 31, 2024 | 5.12 Mn |
| Dec 31, 2024 | 5.12 Mn |
| Sep 30, 2024 | -1.19 Mn |
| Sep 30, 2024 | -1.19 Mn |
| Jun 30, 2024 | -3.02 Mn |
| Jun 30, 2024 | -3.02 Mn |
| Mar 31, 2024 | -1.26 Mn |
| Mar 31, 2024 | -1.26 Mn |
| Dec 31, 2023 | 10.72 Mn |
| Dec 31, 2023 | 10.72 Mn |
| Sep 30, 2023 | -1.69 Mn |
| Sep 30, 2023 | -1.69 Mn |